Immunic Inc. Stock
Price
Target price
€1.20
€1.20
1.360%
0.016
1.360%
€5.48
11:33 / Tradegate
WKN: A2PHD4 / Symbol: IMUX / Name: Immunic / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Immunic Inc. Stock
Immunic Inc. gained 1.360% today.
We see a rather positive sentiment for Immunic Inc. with 6 Buy predictions and 2 Sell predictions.
Based on the current price of 1.2 € the target price of 5 € shows a potential of 318.41% for Immunic Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Immunic Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Immunic Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immunic Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immunic Inc. | 1.360% | -0.422% | -2.158% | -16.855% | -17.552% | -90.191% | - |
| Ocuphire Pharma Inc. | 1.540% | -12.683% | -21.834% | -70.413% | -48.766% | - | - |
| NanoViricides Inc. | -0.960% | -3.704% | 2.970% | -6.306% | 10.053% | -70.029% | -76.817% |
| Synthetic Biologics Inc. | -1.570% | -17.831% | -26.509% | -47.538% | -14.750% | -92.354% | -93.180% |
Comments
Immunic, Inc. (NASDAQ: IMUX) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic, Inc. (NASDAQ: IMUX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for IMUX provided by MarketBeat
Immunic, Inc. (NASDAQ: IMUX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $7.00 price target on the stock.
Show more
Ratings data for IMUX provided by MarketBeat